| ICD-10 Code | Description |
| T80.810A | Extravasation of vesicant antineoplastic chemotherapy, initial encounter |
| T80.810D | Extravasation of vesicant antineoplastic chemotherapy, subsequent encounter |
| T80.810S | Extravasation of vesicant antineoplastic chemotherapy, sequela |
| T80.818A | Extravasation of other vesicant agent, initial encounter |
| T80.818D | Extravasation of other vesicant agent, subsequent encounter |
| T80.818S | Extravasation of other vesicant agent, sequela |
| T80.82XA | Complication of immune effector cellular therapy, initial encounter |
| T80.82XD | Complication of immune effector cellular therapy, subsequent encounter |
| T80.82XS | Complication of immune effector cellular therapy, sequela |
| T80.89XA | Other complications following infusion, transfusion and therapeutic injection, initial encounter |
| T80.89XD | Other complications following infusion, transfusion and therapeutic injection, subsequent encounter |
| T80.89XS | Other complications following infusion, transfusion and therapeutic injection, sequela |
